From funding research grants to minimizing the barriers to clinical trials, the decisions made in Washington, D.C., directly influence the rate of progress in the war against cancer. Issues regarding health and science are becoming increasingly complex, and competition for limited resources is steadily increasing. These times require that cancer researchers become more actively involved in the policy-making process and take time to educate the public about the exciting progress occurring in the fight against cancer.
The AACR's principal means for devising and implementing strategies to influence funding and important biomedical research-related public policy issues through The Science Policy and Government Affairs Committee and its subcommittees:
Science Policy and Government Affairs Committee - Provides guidance on public issues of concern to cancer researchers and focuses on mechanisms for speeding up cancer research.
On October 29, 2013 AACR and AdvaMedDx partnered on a symposium titled “Transforming Cancer Care Through Diagnostics and Personalized Medicine,” in Washington, D.C.
Harold Varmus, M.D., Director of the NCI gave the opening keynote talk on “Why Diagnostics Matter?”. During lunch Charles Sawyers, M.D., President of the AACR facilitated a conversation between Francis Collins, M.D., Director of the NIH and Margaret Hamburg, M.D., Commissioner of the FDA to discuss “The Path to Personalized Medicine: Where are we Today?” -Detailed Event Agenda
More than 250 scientists, patient advocates, NIH and FDA staff, and drug and diagnostic company representatives participated in the symposium. The purpose of the meeting was to shine a spotlight on the state of genomic understanding and discuss the exciting science that is enabling the development of molecular diagnostic tests, which are essential for advancing personalized cancer therapies. In addition, the participants at the conference discussed numerous policy issues, including how diagnostic regulatory pathways can promote patient safety and innovation, how the current payment systems are valuing new diagnostic technologies, and how to ensure that all patients have access to the latest diagnostic technologies.
CANCER POLICY RESOURCES
AACR OFFICE OF SCIENCE POLICY & GOVERNMENT AFFAIRS
1425 K Street, NW, Suite 250
Washington, D.C. 20005
(202) 898-6499 (Phone)
(202) 898-0966 (Fax)